compounding glp-1 fda 🚨 Cracks Down on Compounded GLP-1s – What's Next for Weight Loss? 🚨 Big news in the weight loss world: The FDA is officially shutting down pharmacies producing medications Navigating Access: The Future of

Description

Discover why protein, strength training, and mental health care are critical.

This is clearly established in the FDA drug l...

Featuring 500 million AFUs of Akkermansia muciniphila, Clostridium butyricum, and Bifidobacterium infantis with chicory inulin for gut support

Experiencing GLP-1 hair loss

However, its future trajectory is far from linear as many uncertainties remain, e.g., acceptance of obesity as a chronic disease, budget impact faced by payers and health systems willingness and ability to pay, the readout of further cardiovascular outcomes trials after the high profile results of 2023s SELECT trial for Wegovy, or new entrants challenging first generation therapies with alternative mechanisms of action (MoA) to address shortcomings such as gastrointestinal tolerability, current drugs being injectables, or the durability and quality of weight loss which distinguishes between fat and lean body mass